Orion Pharma Collaborates with Criceto for Aporon to Treat OFF Episodes in Parkinson’s Disease
Shots: Orion & Criceto have entered into an exclusive license agreement to dev...
Shots: Orion & Criceto have entered into an exclusive license agreement to dev...
Shots: Mosaic has in-licensed ASTX029 & ASTX295 from Astex (Otsuka Pharmaceuti...
Shots: Repertoire & Genentech have entered into a collaboration & license...
Shots: BI & Tessellate Bio have entered into a research collaboration & gl...
Shots: FUJIFILM Diosynth Biotechnologies & Regeneron have entered into a 10-ye...
Shots: DAAN Biotherapeutics & GC Cell have entered into an exclusive tech...
Incisive News in 3 Shots.
Modal body text goes here.